Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
24.02 USD | +13.52% | +18.21% | +773.45% |
Apr. 30 | Health Care Flat Amid Mixed Earnings -- Health Care Roundup | DJ |
Apr. 30 | Sector Update: Health Care Stocks Mixed Late Afternoon | MT |
Financials (USD)
Sales 2024 * | 243M | Sales 2025 * | 274M | Capitalization | 628M |
---|---|---|---|---|---|
Net income 2024 * | -77M | Net income 2025 * | -46M | EV / Sales 2024 * | 2.59 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 2.3 x |
P/E ratio 2024 * |
-8.37
x | P/E ratio 2025 * |
-15.3
x | Employees | 1,000 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 70.03% |
Latest transcript on GeneDx Holdings Corp.
1 day | +13.52% | ||
1 week | +18.21% | ||
Current month | +40.71% | ||
1 month | +149.95% | ||
3 months | +375.64% | ||
6 months | +1,534.01% | ||
Current year | +773.45% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 48 | 22-04-28 | |
Kevin Feeley
DFI | Director of Finance/CFO | 43 | - |
Paul Kruszka
CTO | Chief Tech/Sci/R&D Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Joshua Ruch
BRD | Director/Board Member | 74 | 21-07-21 |
Director/Board Member | 68 | 22-04-30 | |
Keith Meister
BRD | Director/Board Member | 51 | 20-12-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.00% | 9 M€ | -.--% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-16 | 24.02 | +13.52% | 629,840 |
24-05-15 | 21.16 | -0.89% | 576,412 |
24-05-14 | 21.35 | -8.68% | 656,817 |
24-05-13 | 23.38 | +12.67% | 1,051,704 |
24-05-10 | 20.75 | +2.12% | 967,968 |
Delayed Quote Nasdaq, May 16, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+773.45% | 628M | |
-16.99% | 8.67B | |
+65.60% | 4.25B | |
-9.46% | 2.47B | |
-0.96% | 2.51B | |
-44.11% | 2.25B | |
-7.42% | 1.91B | |
-18.68% | 1.56B | |
-41.75% | 1.19B | |
+11.31% | 1.15B |
- Stock Market
- Equities
- WGS Stock